SPF numbers are lying to you — here’s the truth

South Africa sits in one of the highest UV-index zones in the world. On a clear summer day in Johannesburg, Durban, or Cape Town, the UV index routinely hits 11 or above — the World Health Organisation’s “extreme” category, where unprotected skin can begin to burn in under 15 minutes. Yet the most common mistake South Africans make at the pharmacy is grabbing the biggest SPF number on the shelf, assuming more digits mean meaningfully more protection. They don’t.

The SPF number tells only half the story

SPF — sun protection factor — measures how much UVB radiation a sunscreen blocks under standardised lab conditions. The maths behind it are simple, but the result surprises most people.

SPF 30 blocks approximately 97% of UVB rays. SPF 50 blocks roughly 98%. SPF 100 blocks about 99%. That gap between SPF 50 and SPF 100 is a single percentage point — not double the protection, not even close. In practical terms, for every 100 UVB photons hitting your skin, SPF 50 lets through two and SPF 100 lets through one. That is a real but clinically modest difference, especially once you factor in the messiness of real-world application.

The reason this misconception is so sticky is partly down to a specific media moment: when the US Food and Drug Administration (FDA) proposed capping SPF labels at “50+” in 2011, headlines worldwide ran with the idea that anything above 50 was “a marketing gimmick.” The proposal was nuanced — the FDA was worried that very high numbers gave consumers false confidence, not that higher-SPF formulas offered zero additional benefit. The rule never passed in the US. South Africa operates under different regulations (more on that below), but the “SPF 100 is a scam” oversimplification spread and lodged itself in popular health culture. The truth is more granular: SPF 100 does block marginally more UVB, but the real protection gap lies somewhere the number on the front of the bottle doesn’t capture at all.

The UVA problem nobody’s talking about

UVB rays cause sunburn and are the primary driver of squamous cell carcinoma. But UVA rays — which penetrate deeper into the dermis — are the dominant cause of photoageing and play a significant role in melanoma development. Here is the critical point: SPF only measures UVB protection. It says nothing about UVA.

South Africa has one of the highest melanoma rates on the African continent among fair-skinned populations, and the Cancer Association of South Africa (CANSA) reports that non-melanoma skin cancers are among the most frequently diagnosed cancers in the country. No current SAMRC dataset breaks down UVA-specific attribution locally, but the global evidence — including World Health Organisation data — consistently shows UVA as a primary melanoma risk driver.

Many sunscreens on South African pharmacy shelves provide adequate UVB coverage but patchy or inadequate UVA coverage. A product with SPF 50 and poor UVA filters is not “broad spectrum” in any meaningful clinical sense, even if it carries that phrase on the label.

How to read a South African sunscreen label

The South African Health Products Regulatory Authority (SAHPRA) classifies sunscreens as cosmetics, not medicines, which affects what manufacturers must prove before selling a product. Under current South African National Standards (SANS) guidelines aligned with international cosmetic frameworks, a product claiming “broad spectrum” protection must demonstrate a UVA protection factor of at least one-third of its SPF rating. So an SPF 30 broad-spectrum product must offer a UVA-PF of at least 10.

That sounds reassuring, but one-third is a floor, not a ceiling. Here is what to look for on the label:

• “Broad spectrum” claim: Required to meet the one-third UVA/SPF ratio minimum.
• PA rating (e.g. PA+++, PA++++): A Japanese grading system increasingly adopted on South African products. PA++++ indicates very high UVA protection. Four plus signs is better than two.
• UVA circle logo: A European standard appearing on some imported products. The UVA-PF must be at least half the SPF — a stricter standard than SAHPRA’s minimum.
• Active ingredients: Zinc oxide and titanium dioxide (physical/mineral filters) block both UVA and UVB. Chemical filters such as avobenzone provide UVA coverage; Tinosorb S and Tinosorb M (bis-ethylhexyloxyphenol methoxyphenyl triazine) offer excellent broad-spectrum coverage and are common in European-formulated products sold locally.

A product that carries only an SPF number with no broad-spectrum claim and no PA rating is telling you — by omission — that its UVA protection is unverified or minimal.

Why reapplication beats a higher number

Here is the most evidence-backed sun protection message that consistently gets drowned out by SPF marketing: when and how much you apply matters far more than the number on the bottle.

Lab SPF testing uses 2 mg of product per square centimetre of skin. Most people apply between 0.5 mg and 1 mg per square centimetre in real life — roughly a quarter to half the tested amount. At half application density, an SPF 50 product performs closer to an SPF 7 in practice. This is not a fringe finding; it is replicated across multiple peer-reviewed studies and underpins all major dermatology guidance.

The South African Skin Cancer Foundation and international bodies including the British Association of Dermatologists both recommend:

1. Apply sunscreen generously — roughly a teaspoon for the face and neck, two tablespoons for the body if exposed.
2. Reapply every two hours, and immediately after swimming, sweating heavily, or towelling off.
3. Apply 20 minutes before sun exposure to allow even coverage.

A bottle of SPF 30 applied correctly and reapplied consistently will protect your skin far better than SPF 100 dabbed on once at 7 AM and forgotten.

What this means for your shopping budget

Sunscreens at South African pharmacies range from around R80 for a basic Neutrogena or Nivea broad-spectrum SPF 30 to R600 or more for high-end SPF 100 formulas. The price jump is rarely justified by the marginal UVB improvement. A better use of that spend: buy a mid-range SPF 30 or 50 with clear broad-spectrum or PA+++ credentials and use it consistently. If your skin is oily or acne-prone, look for non-comedogenic formulations — often available in the R150–R250 range from brands like Eucerin, La Roche-Posay, or locally stocked Bioderma, all widely available at Clicks, Dis-Chem, and most independent pharmacies.

For darker skin tones, white cast from mineral filters (zinc oxide, titanium dioxide) remains a real barrier to consistent use — a legitimate usability concern, not vanity. Hybrid formulas and newer-generation tinted mineral sunscreens address this better than older products. Ask your pharmacist what is in stock locally, as availability varies by region.

Accessing skin care advice in South Africa

Whether you are managing a sun-sensitive condition, have a family history of skin cancer, or simply want personalised product advice, there are accessible routes.

Public sector: Your nearest community health centre (CHC) or public clinic can assess suspicious skin lesions and refer you to a dermatologist at a district or regional hospital. Waiting times for specialist referrals in the public system can be long — in Gauteng and the Western Cape, waits of several months are common — so early presentation is important. CANSA also runs free or subsidised skin screening events periodically; check cansa.org.za for dates in your area.

Private sector: A consultation with a private dermatologist typically costs R900–R1,800 for a first appointment, depending on the practice and province. A GP appointment for a skin check runs R600–R1,100 without medical aid. Some GPs with additional training offer dermoscopy (magnified lesion assessment) at a similar price point.

Medical aid: Skin cancer treatment falls under Prescribed Minimum Benefits (PMBs) once a diagnosis is confirmed, meaning your medical aid must cover treatment costs at a defined minimum level regardless of plan. Routine skin screening and sunscreen purchases are generally not PMB-covered, but preventive consultations may fall within your plan’s preventive care benefit — check your 2025 benefit schedule or call your scheme directly.

Practical barrier: Load-shedding affects refrigerated dermatology products (some prescription creams require cold storage) and disrupts clinic systems. Keep emergency scripts filled before extended outages and ask your pharmacist about storage requirements for any topical medications.

When to see a doctor

See your GP or a dermatologist promptly if you notice:

– A new mole or skin lesion that changes shape, colour, or size

– A sore that does not heal within four weeks

– A dark streak under a nail not caused by injury

– Any lesion that bleeds spontaneously or itches persistently

Early detection of skin cancer is the single biggest factor in outcome. Do not wait for your next routine check if something looks or feels wrong.

Bottom line

• Check the UVA rating, not just the SPF number — look for “broad spectrum,” PA+++/PA++++, or the UVA circle logo on the label.
• Apply enough product — a teaspoon for your face and neck; two tablespoons for exposed body areas — and reapply every two hours.
• SPF 50 vs SPF 100 is a 1% UVB difference; spend the price gap on a second bottle you’ll actually finish.
• Darker skin tones still need sunscreen — UVA-driven damage and melanoma risk exist across all skin tones; choose a formula you’ll use consistently.
• Suspicious lesions need a real consultation — no sunscreen replaces early clinical assessment.